Related Experiment Video

Updated: Aug 16, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Calcium/calmodulin-dependent protein kinases as potential targets in cancer therapy

Oswaldo Rodriguez-Mora1, Michelle M LaHair, Christopher J Howe

  • 1Department of Microbiology and Immunology, Brody School of Medicine, East Carolina University, Greenville, NC 27834, USA.

Expert Opinion on Therapeutic Targets
|August 9, 2005
PubMed

Insights

Calcium/calmodulin-dependent kinases (CaM-kinases) activate antiapoptotic pathways and are activated by oxidative stress. Targeting CaM-kinases may sensitize cancer cells to therapy and induce cell cycle arrest.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Calcium/calmodulin-dependent kinases (CaM-kinases) are crucial regulators of cellular processes.
  • Their role in antiapoptotic signaling pathways is increasingly recognized.
  • Emerging evidence suggests a link between CaM-kinases and cellular responses to oxidative stress.

Purpose of the Study:

  • To review the expression and activation mechanisms of CaM-kinases.
  • To elucidate the role of CaM-kinases in antiapoptotic signaling.
  • To explore the potential of CaM-kinases as therapeutic targets in cancer treatment.

Main Methods:

  • Literature review of studies on CaM-kinase expression, activation, and function.
  • Analysis of signaling pathways regulated by CaM-kinases, including antiapoptotic and cell cycle pathways.
  • Discussion of novel activation mechanisms, such as oxidative stress-induced activation.

Main Results:

  • CaM-kinases play a significant role in activating antiapoptotic signaling pathways.
  • A novel mechanism for CaM-kinase activation by oxidative stress has been identified.
  • CaM-kinases are implicated in cell transformation and cell cycle regulation.

Conclusions:

  • CaM-kinases are promising targets for sensitizing cancer cells to therapeutic treatments.
  • Inhibition of CaM-kinases may induce cytostasis and enhance cancer therapy efficacy.
  • Further research into CaM-kinase regulation and function could lead to novel cancer treatment strategies.

More Related Videos

Screening Ion Channels in Cancer Cells06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...